Teladoc Health (NYSE:TDOC) Releases Q1 2026 Earnings Guidance

Teladoc Health (NYSE:TDOC) updated its first quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of -0.450–0.350 for the period, compared to the consensus estimate of -0.280. The company issued revenue guidance of $598.0 million-$620.0 million, compared to the consensus revenue estimate of $632.9 million. Teladoc Health also updated its FY 2026 guidance to -1.100–0.700 EPS.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Zacks Research downgraded Teladoc Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. Weiss Ratings reissued a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday, December 29th. Citigroup lowered their price objective on Teladoc Health from $10.00 to $9.00 and set a “neutral” rating for the company in a research report on Friday, January 9th. Evercore decreased their target price on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a research report on Thursday, October 30th. Finally, Barclays assumed coverage on Teladoc Health in a report on Tuesday, December 9th. They set an “equal weight” rating and a $8.50 price objective for the company. Three analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $9.12.

Teladoc Health Stock Up 2.5%

TDOC traded up $0.12 on Wednesday, reaching $4.66. The company’s stock had a trading volume of 6,087,236 shares, compared to its average volume of 6,532,484. The business’s 50 day moving average is $6.11 and its 200 day moving average is $7.24. Teladoc Health has a 1 year low of $4.40 and a 1 year high of $11.55. The stock has a market cap of $826.12 million, a price-to-earnings ratio of -3.64 and a beta of 2.12. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, February 25th. The health services provider reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.05. The business had revenue of $642.27 million during the quarter, compared to the consensus estimate of $635.33 million. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. As a group, research analysts forecast that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Transactions at Teladoc Health

In related news, insider Carlos Nueno sold 3,897 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total transaction of $29,188.53. Following the sale, the insider directly owned 27,175 shares of the company’s stock, valued at approximately $203,540.75. This represents a 12.54% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Fernando M. Rodrigues sold 4,209 shares of Teladoc Health stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total transaction of $31,483.32. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 33,288 shares of company stock worth $251,684 in the last quarter. Insiders own 0.58% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in TDOC. IFP Advisors Inc lifted its position in shares of Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 3,210 shares during the last quarter. PNC Financial Services Group Inc. raised its position in shares of Teladoc Health by 177.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after purchasing an additional 2,810 shares during the period. Van ECK Associates Corp lifted its holdings in shares of Teladoc Health by 101.4% during the fourth quarter. Van ECK Associates Corp now owns 9,150 shares of the health services provider’s stock valued at $64,000 after purchasing an additional 4,607 shares during the last quarter. Johnson Financial Group Inc. lifted its holdings in shares of Teladoc Health by 41,045.8% during the third quarter. Johnson Financial Group Inc. now owns 9,875 shares of the health services provider’s stock valued at $76,000 after purchasing an additional 9,851 shares during the last quarter. Finally, Cibc World Markets Corp acquired a new position in shares of Teladoc Health in the 4th quarter valued at $82,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.